Results 1 to 10 of about 3,600 (117)
Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still’s disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still’s Disease Registry [PDF]
Frontiers in ImmunologyObjectivesThis study aims to explore the application of machine learning techniques in assessing macrophage activation syndrome (MAS) in Still’s disease.MethodsA multicenter, observational, prospective study was conducted, including patients with Still’s Piero Ruscitti, Francesco Masedu, Antonio Vitale, Antonio Vitale, Valeria Caggiano, Valeria Caggiano, Ilenia Di Cola, Fabiola Atzeni, Jessica Sbalchiero, Jessica Sbalchiero, Giuseppe Lopalco, Florenzo Iannone, Maria Morrone, Daniela Iacono, Flavia Riccio, Mariachiara Visconti, Carla Gaggiano, Carla Gaggiano, Francesco Caso, Giacomo Emmi, Giacomo Emmi, Giacomo Emmi, Andrea Hinojosa-Azaola, Jiram Torres-Ruiz, Eduardo Martín-Nares, Giuliana Guggino, Lidia La Barbera, Ezgi D. Batu, Seza Ozen, Petros P. Sfikakis, Luca Navarini, Luca Navarini, Luisa Costa, Abdurrahman Tufan, Ibrahim Yahya Cakir, Federico Perosa, José Hernández-Rodríguez, Marcella Prete, Lorenzo Dagna, Lorenzo Dagna, Corrado Campochiaro, Corrado Campochiaro, Francesco Ursini, Francesco Ursini, Paolo Sfriso, Sara Bindoli, Henrique A. Mayrink Giardini, Lampros Fotis, Katerina Kourtesi, Gaafar Ragab, Mahmoud Ghanema, Moustafa Ali Saad, Haner Direskeneli, Anastasios Karamanakos, Alessandro Conforti, Francesco La Torre, Micol Frassi, Marcello Govoni, Paola Parronchi, Piercarlo Sarzi-Puttini, Maria Cristina Maggio, Serena Bugatti, Serena Bugatti, Ludovico De Stefano, Ludovico De Stefano, Jacopo Pelizza, Jacopo Pelizza, Elena Bartoloni, Donato Rigante, Annamaria Iagnocco, Ombretta Viapiana, Ewa Wiesik-Szewczyk, Joanna Makowska, Özgül Soysal Gündüz, Şükran Erten, Benson Ogunjimi, Benson Ogunjimi, Benson Ogunjimi, Benson Ogunjimi, Gian Domenico Sebastiani, Emanuela Del Giudice, Edoardo Biancalana, Giovanni Conti, Ibrahim A. AlMaghlouth, Ibrahim A. AlMaghlouth, Luciana Breda, Antonio Gidaro, Patrizia Barone, Alma Nunzia Olivieri, Francesco Carubbi, Amato De Paulis, Maria Sole Chimenti, Alberto Lo Gullo, Samar Tharwat, Samar Tharwat, Maissa Thabet, Abdelhfeez Moshrif, Maria Alessio, Angela Mauro, Benoit Suzon, Benoit Suzon, Valentina Pucino, Oksana Boyarchuk, Tetiana Kovalchuk, Cemal Bes, Rabia Deniz, Sulaiman M. Al-Mayouf, Paola Cipriani, Marco Valenti, Alberto Balistreri, Claudia Fabiani, Claudia Fabiani, Francesco Ciccia, Carlomaurizio Montecucco, Carlomaurizio Montecucco, Roberto Giacomelli, Roberto Giacomelli, Bruno Frediani, Bruno Frediani, Luca Cantarini, Luca Cantarini +120 moredoaj +2 more sourcesAdult-onset Still’s disease with dermatomyositis-like lesions [PDF]
European Journal of Case Reports in Internal MedicineStill’s disease is an inflammatory disorder of unknown origin, also known as juvenile idiopathic arthritis, that predominantly affects children, as it usually appears before the age of 16. However, there is another presentation known as adult-onset Still’Inés Segovia Rodríguez, Juan Vicente de la Sota, Alba Hernández Piriz, María Castillo Gutiérrez, Teresa López Bernal, Beatriz Aranegui Arteaga, Elena García Guijarro +6 moredoaj +2 more sourcesAdult Still’s disease – a multidisciplinary disease [PDF]
Archives of the Balkan Medical Union, 2021 Introduction. Adult-onset Still’s disease is a rare systemic autoinflammatory disorder of unknown etiology, characterized by persistent fever, maculopapular skin rash, and arthritis or arthralgia.Leonid I. DVORETSKY, Daria V. NOVIKOVA, Anna V. TORGASHNA, Alla M. KOVRIGINA, Tatiana N. MOISEEVA, Roza M. VAKOLYUK, Maria A. KARNAUSHKINA +6 moredoaj +1 more sourceElderly-onset adult Still’s disease
Rheumatology, 2021 Adult-onset Still’s disease is a rare inflammatory disorder usually affecting young adults. Elderly-onset Still’s disease (EOSD) is reported in some cases, commonly in Japan, the USA and Europe.Anis Mzabi, Rym Fakhfakh, Maissa Thabet, Imen Ben Hassine, Jihed Anoun, Monia Karmani, Fatma Ben Fredj, Chadia Laouani +7 moredoaj +1 more sourceStill’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry
RMD Open, 2023 Objective Still’s disease is more frequently observed in the paediatric context, but a delayed onset is not exceptional both in the adulthood and in the elderly.Micol Frassi, Marcello Govoni, Annamaria Iagnocco, Florenzo Iannone, Paola Triggianese, Corrado Campochiaro, Sara Monti, Maria G Tektonidou, Eduardo Martin-Nares, Piero Ruscitti, Roberto Giacomelli, Luca Cantarini, Giuseppe Lopalco, Lorenzo Dagna, Francesco Carubbi, Alma Nunzia Olivieri, Antonio Vitale, Ombretta Viapiana, Fatma Alibaz-Öner, Haner Direskeneli, Petros P Sfikakis, Giacomo Emmi, Claudia Fabiani, Gabriele Simonini, Francesco Ciccia, Elena Bartoloni, Alessandro Tomelleri, Daniela Iacono, Riza Can Kardas, Bruno Frediani, Benson Ogunjimi, Amato de Paulis, Onorina Berardicurti, Alessandro Conforti, Ilenia Di Cola, Anastasios Karamanakos, Katerina Laskari, Abdurrahman Tufan, Stefania Costi, José Hernández-Rodríguez, Lampros Fotis, Jurgen Sota, Antonio Gidaro, Ewa Wiesik-Szewczyk, Gian Domenico Sebastiani, Jiram Torres-Ruiz, Paolo Sfriso, Giovanni Conti, Luca Navarini, Francesco La Torre, Samar Tharwat, Andrea Hinojosa-Azaola, Alberto Lo Gullo, Valeria Caggiano, Ibrahim A Almaghlouth, Kazi Asfina, Gafaar Ragab, Maria Cristina Maggio, Joanna Makowska, Emanuela Del Giudice, Armin Maier, Sukran Erten, Henrique A Mayrink Giardini, Maria Morrone, Isabele Parente de Brito Antonelli, Marilia Ambiel Dagostin, Martina Patrone, Fehaid Alanazi, Carla Gaggiano, Hamit Kucuk, Ayman Abdel-Monem Ahmed Mahmoud, Katerina Kourtesi, Maria Tarsia, Verónica Gómez-Caverzaschi, Angela Mauro, Alberto Balistreri +75 moredoaj +1 more sourceCanakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry
Frontiers in Medicine, 2022 ObjectiveInterleukin (IL)-1 inhibitors are largely employed in patients with Still’s disease; in cases with refractory arthritis, IL-6 inhibitors have shown to be effective on articular inflammatory involvement.Antonio Vitale, Valeria Caggiano, Maria Cristina Maggio, Giuseppe Lopalco, Giacomo Emmi, Giacomo Emmi, Jurgen Sota, Francesco La Torre, Piero Ruscitti, Elena Bartoloni, Giovanni Conti, Claudia Fabiani, Irene Mattioli, Carla Gaggiano, Fabio Cardinale, Lorenzo Dagna, Lorenzo Dagna, Corrado Campochiaro, Roberto Giacomelli, Alberto Balistreri, Katerina Laskari, Abdurrahman Tufan, Gaafar Ragab, Gaafar Ragab, Ibrahim A. Almaghlouth, Ibrahim A. Almaghlouth, Ewa Więsik-Szewczyk, Rosa Maria Pereira, Bruno Frediani, Florenzo Iannone, Petros P. Sfikakis, Luca Cantarini +31 moredoaj +1 more sourceAdult-onset Still’s Disease: A Case Report
Journal of Nepal Medical Association, 2023
Pyrexia of unknown origin refers to a fever of over 38.3°C on multiple occasions for at least three weeks without a known aetiology, even after a week of hospitalization.Bikash Karki, Niranjan K C, Arun Kumar Mahato, Saksham Kandel, Prakash Acharya +4 moredoaj +1 more source